Related Experiment Video
Updated: Oct 22, 2025

08:56
Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults
Published on: November 7, 2014
14.0K
Camera-based objective measures of Parkinson's disease gait features
Jannis van Kersbergen1, Karen Otte2,3,4, Nienke M de Vries5
1Eindhoven University of Technology, 5612 AJ, Eindhoven, The Netherlands.
BMC Research Notes
|August 27, 2021
Summary
Consumer depth cameras can detect Parkinson's disease gait differences in step length and walking speed between patients and healthy individuals. Further development is needed to monitor medication effects.
Area of Science:
- Biomedical Engineering
- Neurology
- Rehabilitation Technology
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder impacting gait and motor function.
- Advancements in consumer imaging technology offer potential for accessible home-based diagnostics and monitoring.
- Gait analysis is crucial for assessing PD progression and treatment efficacy.
Purpose of the Study:
- To evaluate the efficacy of a consumer depth camera (Microsoft Kinect V2) in capturing gait alterations in Parkinson's disease patients.
- To compare gait parameters derived from depth camera recordings with clinical assessments.
- To investigate the camera's ability to differentiate between PD patients and healthy controls.
Main Methods:
- A pilot study involving 19 Parkinson's disease patients (tested ON and OFF medication) and 8 healthy controls.
- Participants performed the Timed-Up-and-Go test while recorded using a Microsoft Kinect V2 sensor.
- Gait features extracted included step length, average walking speed, and mediolateral sway; clinical assessment used the MDS-UPDRS scale.
Main Results:
- Significant differences in step length and average walking speed were observed between Parkinson's patients and controls.
- The depth camera successfully identified key gait features characteristic of Parkinson's disease.
- No significant differences in gait parameters were detected between the ON and OFF medication states for patients.
Conclusions:
- Consumer depth cameras show promise for detecting group-level gait differences in Parkinson's disease.
- Current technology requires further refinement to enable sensitive detection of intra-individual changes related to medication status.
- This technology could potentially support remote monitoring and management of Parkinson's disease in the future.
Related Concept Videos
Parkinson's Disease: Overview
887
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887
Parkinson's Disease: Treatment
469
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
469

